Stifel Nicolaus is most often covered alongside Weiss Ratings, which appears in 10 of these 18 stories. That works out to roughly 0.7 stories per week across a 176-day span. The busiest single day carried 3. Coverage clusters in markets, which accounts for 5 of those 18, with the remainder spread across 8 other categories.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Stifel Nicolaus
Stifel Nicolaus is most often covered alongside Weiss Ratings, which appears in 10 of these 18 stories. That works out to roughly 0.7 stories per week across a 176-day span. The busiest single day carried 3. Coverage clusters in markets, which accounts for 5 of those 18, with the remainder spread across 8 other categories. The tracked stories average 2.1 original sources each. 11% of these stories carry negative sentiment. Stifel Nicolaus appears in 18 tracked Cross-Sector stories published from February 19, 2026 through August 13, 2026.
Stories tracked
18
Per week
0.7
Negative
11%
Sources per story
2.1
Computed from the 18 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Stifel Nicolaus. Shared-story counts are live from our verified record — not editorial picks.
Wall Street Zen cut both Klaviyo and Oceaneering International from Buy to Hold in Saturday research notes.
Citigroup lifts KVYO target
Citigroup raised its Klaviyo price target from $34.00 to $36.00 with a Buy rating.
KVYO analyst revisions
Stephens, BTIG, Stifel, and Truist adjusted price targets on Klaviyo following earnings.
Klaviyo Q2 earnings
Klaviyo reported EPS of $0.19, meeting consensus, and revenue of $370.58 million.
OII insider sale
SVP Christopher J. Dyer sold 1,200 OII shares at an average price of $47.65 for $57,180.
Weiss upgrades OII
Weiss Ratings raised OII from Buy (B-) to Buy (B).
Barclays lifts OII target
Barclays increased its OII price objective from $39.00 to $47.00 with an Equal Weight rating.
Wells Fargo Cuts Target to $70
Wells Fargo & Company lowers Freshpet’s price target from $75.00 to $70.00, keeping an Overweight rating, implying 28.42% upside.
Bank of America Lowers Target
Bank of America reduces its price target from $75.00 to $70.00 and maintains a Neutral rating.
Citigroup raises OII target
Citigroup raised its Oceaneering target from $35.00 to $40.00 with a Neutral rating.
Piper Sandler Stays Overweight
Piper Sandler reaffirms an Overweight rating on Freshpet shares.
Network 2.0 Milestone
Expected completion of major regional facility consolidations.
Weiss Ratings Downgrades
Weiss Ratings cuts Freshpet from 'Hold (c)' to 'Hold (c-)'.
JPMorgan Upgrades, Others Reaffirm
JPMorgan raises rating from Neutral to Overweight and lifts target from $66.00 to $68.00. Morgan Stanley reiterates Overweight with $77.00 target, while Deutsche Bank holds at Hold with $63.00 target.
TD Cowen lifts OII target
TD Cowen raised its Oceaneering International price target from $34.00 to $36.00 with a Hold rating.
Jefferies Cuts Target
Jefferies Financial Group lowers its price objective from $75.00 to $70.00 and maintains a Hold rating.
TD Cowen Turns Bullish
TD Cowen upgrades Freshpet from Hold to Buy and sets an $80.00 price objective.
Stifel Upgrade
Stifel Nicolaus raises price target to $425.00 following earnings dazzle.
Oppenheimer Upgrades Freshpet
Oppenheimer raises Freshpet from Market Perform to Outperform with an $80.00 price target.
FY26 Guidance Raise
FedEx increases EPS outlook to $19.30-$20.10 citing B2B growth.
SaaS and cloud operators are watching Klaviyo as a high-multiple vertical SaaS proxy. Wall Street Zen's Buy-to-Hold cut, after Q2 revenue of $370.58 million and EPS in line, shows how quickly a premium valuation can compress when growth doesn't exceed expectations.
Marketing and AdTech teams relying on Klaviyo face new investor scrutiny after Wall Street Zen cut the stock to Hold despite Q2 revenue of $370.58 million and in-line EPS of $0.19. The downgrade lands as analyst targets diverge while the company trades at a 895.95 P/E, raising questions about martech spending sustainability.
Wall Street Zen downgraded both Oceaneering International and Klaviyo from Buy to Hold, spotlighting two $5 billion market-cap companies with vastly different P/E ratios—14.59 for OII and 895.95 for KVYO. The ratings actions come as consensus targets diverge from current prices.
Spyglass Pharma's stock plunges to a new 52-week low of $17.56 despite a consensus 'Moderate Buy' rating and an average analyst target of $45. For biotech investors, the 156% upside potential must be weighed against a recent earnings miss and a downgrade to sell, raising questions about near-term pipeline catalysts.
MaxLinear and CoreWeave posted strong gains on thin volume, reflecting divergent investor views on cloud and AI infrastructure. While MaxLinear’s data-center connectivity chips benefit from SaaS growth, CoreWeave’s GPU cloud underpins the growing demand for AI-powered SaaS applications. The moves underscore the high-risk, high-reward dynamics shaping the software-as-a-service supply chain.
Two firms critical to the AI ecosystem—MaxLinear and CoreWeave—rallied on July 20, 2026, but volume data hints at fragile confidence. MaxLinear’s semiconductor solutions enable high-speed data transfer for AI clusters, while CoreWeave’s GPU cloud is a direct infrastructure play. The moves highlight investors’ growing selectivity in AI-linked stocks as earnings volatility mounts.
Needham & Company’s reasserted Buy rating on ServiceTitan, with a $100 price target, underscores the growing confidence in cloud-based platforms that digitize home and commercial service trades. For PropTech investors, the move highlights how essential service management software is becoming within the real estate ecosystem.
Crocs, Inc. issued Q3 2026 guidance below expectations, with EPS of $3.20-$3.30 and revenue of $996.3 million, missing the consensus of $3.55 and $1.0 billion, respectively. The shortfall triggered a 7.4% stock decline, raising concerns about softening consumer demand for casual footwear heading into the back-to-school season.
AXT blew past Q3 consensus with EPS guidance of $0.30-$0.32 vs. $0.10 and revenue of $66M vs. $38.7M, while Crocs missed with $3.20-$3.30 EPS vs. $3.55 and $996.3M revenue vs. $1.0B. The split paints a complex picture for investors, highlighting a semiconductor super-cycle amid softening consumer discretionary.
Monarch Casino & Resort posted a second-quarter earnings beat of $0.11 per share on revenue strength, driving the stock up 1.1% to $124.38. Valuation metrics remain solid with a P/E of 21.08 and a 1% dividend yield, but a recent CEO stock sale and mixed analyst ratings signal a cautious bias. Truist’s $144 price target offers the most bullish outlook, while Stifel sits at $102.
Wells Fargo lowered its price target on Freshpet to $70 from $75 while maintaining an Overweight rating, implying the stock is undervalued by 28%. The market remains skeptical with FRPT trading at $54.51, well below the consensus analyst target of $74.25. Analysts overall rate the pet food company a Moderate Buy, despite a string of recent target cuts.
AeroVironment’s lower FY2027 outlook pours cold water on defense drone growth expectations despite a strong quarter. The EPS midpoint of $3.18 vs. $3.95 consensus raises questions about the pace of U.S. and allied UAV procurement and signals a potential reset in the tactical drone market’s investment thesis.
Stifel Nicolaus has significantly increased its price target for FedEx to $425.00, reflecting growing confidence in the logistics giant's structural transformation. The upgrade follows a record-breaking peak season and a raised FY 2026 earnings outlook driven by the successful integration of its Express and Ground networks.
Stifel Nicolaus has significantly raised its price target for FedEx to $425.00, signaling strong confidence in the logistics giant's 'One FedEx' consolidation and 'Network 2.0' efficiency gains. The upgrade follows a record-breaking peak season and an upward revision of fiscal 2026 earnings guidance.
BMO Capital Markets has adjusted its price target for CrowdStrike from $555 to $500 while maintaining an Outperform rating. The revision reflects a broader trend of valuation normalization within the high-growth cybersecurity sector despite strong platform fundamentals.
BMO Capital Markets and other major financial institutions have lowered their price targets for CrowdStrike (CRWD) following its Q4 2026 earnings report. Despite the target reduction to $500, analysts maintain an 'Outperform' rating, signaling long-term confidence in the company's platform strategy.
Rivian Automotive shares fell over 7% on Tuesday, retreating from a recent post-earnings rally as investors weighed the execution risks of the upcoming R2 SUV launch. Despite several Wall Street firms raising price targets following a fourth-quarter gross profit beat, the market remains cautious about the company's path to sustained profitability in 2026.
Rivian Automotive shares fell over 7% despite several Wall Street firms raising price targets following a strong Q4 performance. Investors are increasingly focused on the critical R2 SUV launch, which remains the primary catalyst for the company's goal of achieving full-year gross profitability by 2026.